Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8187879rdf:typepubmed:Citationlld:pubmed
pubmed-article:8187879lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:8187879lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:8187879lifeskim:mentionsumls-concept:C1704708lld:lifeskim
pubmed-article:8187879lifeskim:mentionsumls-concept:C0205225lld:lifeskim
pubmed-article:8187879lifeskim:mentionsumls-concept:C1521840lld:lifeskim
pubmed-article:8187879lifeskim:mentionsumls-concept:C0056661lld:lifeskim
pubmed-article:8187879pubmed:issue2-3lld:pubmed
pubmed-article:8187879pubmed:dateCreated1994-6-22lld:pubmed
pubmed-article:8187879pubmed:abstractTextThe liver-specific toxin microcystin-LR (MC-LR) is a potent inhibitor of type 1 (PP1) and type 2A (PP2A) protein phosphatases. A tritiated form of the toxin, [3H]dihydromicrocystin-LR ([3H]DMC-LR), was used to identify target proteins in cellular fractions prepared from rat liver homogenates. About 80% of the [3H]DMC-LR bound to proteins was in the cytosolic fraction, which contained essentially all of the PP2A. In contrast, much of the PP1 was found in particulate fractions, each with only a few percent of the total protein-bound [3]HDMC-LR. Protein-bound [3H]DMC-LR in the cytosol co-eluted with PP2A, but not with PP-1 from a DEAE-Sepharose column. Native forms of liver cytoplasmic PP2A and PP1 separated by aminohexyl-Sepharose adsorption showed similar sensitivity to inhibition by MC-LR, and bound [3H]DMC-LR proportional to the amount of phosphatase activity. The results indicate that [3H]DMC-LR can bind both PP2A and PP1 in the liver which must be important for microcystin-induced toxicity, but is recovered mainly bound to PP2A in the cytosol.lld:pubmed
pubmed-article:8187879pubmed:languageenglld:pubmed
pubmed-article:8187879pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187879pubmed:citationSubsetIMlld:pubmed
pubmed-article:8187879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187879pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8187879pubmed:statusMEDLINElld:pubmed
pubmed-article:8187879pubmed:monthMaylld:pubmed
pubmed-article:8187879pubmed:issn0014-5793lld:pubmed
pubmed-article:8187879pubmed:authorpubmed-author:BrautiganD...lld:pubmed
pubmed-article:8187879pubmed:authorpubmed-author:ErikssonJ EJElld:pubmed
pubmed-article:8187879pubmed:authorpubmed-author:ToivolaD MDMlld:pubmed
pubmed-article:8187879pubmed:issnTypePrintlld:pubmed
pubmed-article:8187879pubmed:day16lld:pubmed
pubmed-article:8187879pubmed:volume344lld:pubmed
pubmed-article:8187879pubmed:ownerNLMlld:pubmed
pubmed-article:8187879pubmed:authorsCompleteYlld:pubmed
pubmed-article:8187879pubmed:pagination175-80lld:pubmed
pubmed-article:8187879pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:meshHeadingpubmed-meshheading:8187879-...lld:pubmed
pubmed-article:8187879pubmed:year1994lld:pubmed
pubmed-article:8187879pubmed:articleTitleIdentification of protein phosphatase 2A as the primary target for microcystin-LR in rat liver homogenates.lld:pubmed
pubmed-article:8187879pubmed:affiliationDepartment of Biology, Abo Akademi University, Turku, Finland.lld:pubmed
pubmed-article:8187879pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8187879pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8187879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8187879lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8187879lld:pubmed